clinical trial | Q30612 |
P3098 | ClinicalTrials.gov ID | NCT01962636 |
P17 | country | United States of America | Q30 |
P582 | end time | 2023-10-01 | |
P921 | main subject | follicular lymphoma | Q123251 |
prolymphocytic leukemia | Q2112719 | ||
P4135 | maximum age | 55 | |
P1050 | medical condition | leukemia | Q29496 |
lymphoma | Q208414 | ||
multiple myeloma | Q467635 | ||
Burkitt lymphoma | Q1016605 | ||
chronic idiopathic myelofibrosis | Q3857106 | ||
P1132 | number of participants | 200 | |
P4844 | research intervention | fludarabine phosphate | Q185916 |
(RS)-cyclophosphamide | Q408524 | ||
P6153 | research site | University of Minnesota | Q238101 |
P580 | start time | 2016-12-01 | |
P8363 | study type | interventional study | Q78089383 |
P1476 | title | Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for the Treatment of Hematological Diseases |